B4galt5 - UDP-Gal:betaGlcNAc beta 1,4-galactosyltransferase, polypeptide 5 Gene

Also Known as 9430078I07Rik

Species: Mus musculus

Gene Type: protein coding
Gene ID: 56336

Summary

Enables N-acetyllactosamine synthase activity and UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity. Involved in several processes, including ganglioside biosynthetic process via lactosylceramide; neurogenesis; and positive regulation of embryonic development. Acts upstream of or within poly-N-acetyllactosamine biosynthetic process. Predicted to be located in membrane. Predicted to be integral component of membrane. Predicted to be active in Golgi apparatus. Is expressed in several structures, including epithelium; genitourinary system; heart; nervous system; and respiratory system. Orthologous to human B4GALT5 (beta-1,4-galactosyltransferase 5). [provided by Alliance of Genome Resources, Apr 2022]

B4galt5 Products (1)

mRNA Protein Name
NM_019835.2 NP_062809.2 beta-1,4-galactosyltransferase 5

Gene Ontology

  • Molecular Function
  • Biological Process
Molecular Function GO Annotation Evidence References Source
enables N-acetyllactosamine synthase activity IMP
IMP: Inferred from mutant phenotype
20417617 MGI
enables UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity IMP
IMP: Inferred from mutant phenotype
20574042 MGI
Biological Process GO Annotation Evidence References Source
involved in central nervous system myelination IMP
IMP: Inferred from mutant phenotype
30114188 MGI
involved in central nervous system neuron axonogenesis IMP
IMP: Inferred from mutant phenotype
30114188 MGI
involved in ganglioside biosynthetic process via lactosylceramide IMP
IMP: Inferred from mutant phenotype
30114188 MGI
involved in neuron maturation IMP
IMP: Inferred from mutant phenotype
30114188 MGI
acts upstream of or within poly-N-acetyllactosamine biosynthetic process IMP
IMP: Inferred from mutant phenotype
20417617 MGI
involved in positive regulation of embryonic development IMP
IMP: Inferred from mutant phenotype
20574042 MGI
involved in protein glycosylation IMP
IMP: Inferred from mutant phenotype
29415997 MGI
involved in regulation of protein stability IMP
IMP: Inferred from mutant phenotype
29415997 MGI
EXP: Inferred from Experiment IDA: Inferred from direct assay IPI: Inferred from physical interaction IMP: Inferred from mutant phenotype IGI: Inferred from genetic interaction IEP: Inferred from expression pattern
Protein Preferred Names Protein Names

beta-1,4-galactosyltransferase 5

  • UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 5

  • UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 5

  • b4Gal-T5

  • beta-1,4-GalT II

  • beta-1,4-GalTase 5

  • beta-1,4-galactosyltransferase V

  • beta4Gal-T5

  • glucosylceramide beta-1,4-galacto

Related Agents

  • Pre-clinical Phase

Pre-clinical Phase

Bioactive Molecules (4)
Cat. No. Product Name
Effect
Purity
Rare Diseases
HY-114364 UDP-Galactose disodium Agonist 99.73% Unkown
HY-RS01323 B4GALT5 Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS19086 B4galt5 Mouse Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS25576 B4galt5 Rat Pre-designed siRNA Set A Pre-designed Set / Unkown

Orthologs Information

Species Symbol Source ID
Homo sapiens B4galt5 NCBI NCBI:9334